Q3 FY26 results: consolidated PAT turns positive; subsidiary going concern flagged
HEALTHX · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.9 pts less than Nifty Microcap 250 and 0.3 pts more than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Sastasundar Ventures reported Q3 FY26 results. Consolidated revenue grew about 23% YoY to Rs 34,574 lakhs; consolidated PAT turned to Rs 37 lakhs profit from Rs 3,719 lakhs loss (9M PAT of Rs 1,151 lakhs vs Rs 15,111 lakhs loss). Standalone (a Core Investment Company) posted Rs 41 lakhs loss vs Rs 10 lakhs loss. Auditor flagged going concern uncertainty at step-down subsidiary Genu Path Labs whose net worth is fully eroded. An exceptional item of Rs 17 lakhs impairment loss was booked. Subsidiary SHBL completed a Rs 10,000 lakhs buyback from Mitsubishi, raising parent stake to 78.89%.
Consolidated turnaround is encouraging; however going concern flag at Genu Path Labs and continued standalone losses remain areas to watch for investors.